234 related articles for article (PubMed ID: 19339805)
41. The evaluation of new classification of Allergic Rhinitis in patients referred to a clinic in the city of Shiraz.
Alyasin S; Amin R
Iran J Allergy Asthma Immunol; 2007 Mar; 6(1):27-31. PubMed ID: 17303926
[TBL] [Abstract][Full Text] [Related]
42. ARIA-suggested drugs for allergic rhinitis: what impact on quality of life? A GA2LEN review.
Baiardini I; Braido F; Tarantini F; Porcu A; Bonini S; Bousquet PJ; Zuberbier T; Demoly P; Canonica GW;
Allergy; 2008 Jun; 63(6):660-9. PubMed ID: 18445183
[TBL] [Abstract][Full Text] [Related]
43. Characteristics of patients with allergic polysensitization: the POLISMAIL study.
Ciprandi G; Alesina R; Ariano R; Aurnia P; Borrelli P; Cadario G; Capristo A; Carosso A; Casino G; Castiglioni G; Cesinaro Di Rocco P; Colangelolo C; Di Gioacchino M; Di Paola MG; Errico G; Fiorina A; Gambuzza F; Gangemi S; Gasparini A; Giugno R; Iemoli E; Isola S; Maniero G; Marengo F; Mazzali P; Minelli M; Mosca M; Pellegrino R; Piconi S; Pravettoni V; Quaglio L; Ricciardi L; Ridolo E; Sillano V; Valle C; Varin E; Verini M; Zambito M; Riario-Sforza GG; Incorvaia C; Puccinelli P; Scurati S; Frati F
Eur Ann Allergy Clin Immunol; 2008 Nov; 40(3):77-83. PubMed ID: 19334371
[TBL] [Abstract][Full Text] [Related]
44. Bilastine and quality of life.
Jáuregui I; Bartra J; del Cuvillo A; Dávila I; Ferrer M; Montoro J; Mullol J; Sastre J; Valero A
J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():16-23. PubMed ID: 22185046
[TBL] [Abstract][Full Text] [Related]
45. Comparison of ebastine with cetirizine.
Volkerts ER
Ann Allergy Asthma Immunol; 1997 Nov; 79(5):465-6. PubMed ID: 9396983
[No Abstract] [Full Text] [Related]
46. Congruence between international guidelines and mite specific immunotherapy prescribing practices.
Antonicelli L; Braschi MC; Bilò MB; Angino A; Pala AP; Baldacci S; Maio S; Bonifazi F
Respir Med; 2011 Oct; 105(10):1441-8. PubMed ID: 21628094
[TBL] [Abstract][Full Text] [Related]
47. ARIA (Allergic Rhinitis and Its Impact on Asthma) classification of allergic rhinitis severity in clinical practice in France.
Bousquet PJ; Bousquet-Rouanet L; Co Minh HB; Urbinelli R; Allaert FA; Demoly P
Int Arch Allergy Immunol; 2007; 143(3):163-9. PubMed ID: 17284924
[TBL] [Abstract][Full Text] [Related]
48. The correlation between nasal symptom and mucociliary clearance in allergic rhinitis.
Kirtsreesakul V; Somjareonwattana P; Ruttanaphol S
Laryngoscope; 2009 Aug; 119(8):1458-62. PubMed ID: 19507239
[TBL] [Abstract][Full Text] [Related]
49. Allergic rhinitis: treatment based on patient profiles.
Prenner BM; Schenkel E
Am J Med; 2006 Mar; 119(3):230-7. PubMed ID: 16490466
[TBL] [Abstract][Full Text] [Related]
50. Allergic rhinitis in children: incidence and treatment in Dutch general practice in 1987 and 2001.
de Bot CM; Moed H; Schellevis FG; de Groot H; van Wijk RG; van der Wouden JC
Pediatr Allergy Immunol; 2009 Sep; 20(6):571-7. PubMed ID: 19067886
[TBL] [Abstract][Full Text] [Related]
51. A double-blind placebo-controlled study of the efficacy and tolerability of ebastine against hayfever in general practice patients.
Ankier SI; Warrington SJ
J Intern Med; 1989 Dec; 226(6):453-8. PubMed ID: 2577377
[TBL] [Abstract][Full Text] [Related]
52. Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis.
Demoly P; Bousquet PJ; Mesbah K; Bousquet J; Devillier P
Clin Exp Allergy; 2013 Aug; 43(8):881-8. PubMed ID: 23889242
[TBL] [Abstract][Full Text] [Related]
53. Allergic Rhinitis and its impact on asthma update (ARIA 2008). The Belgian perspective.
Bachert C; Jorissen M; Bertrand B; Khaltaev N; Bousquet J
B-ENT; 2008; 4(4):253-7. PubMed ID: 19227033
[TBL] [Abstract][Full Text] [Related]
54. Re-treatment with omalizumab at one year interval for Japanese cedar pollen-induced seasonal allergic rhinitis is effective and well tolerated.
Ogino S; Nagakura T; Okubo K; Sato N; Takahashi M; Ishikawa T
Int Arch Allergy Immunol; 2009; 149(3):239-45. PubMed ID: 19218816
[TBL] [Abstract][Full Text] [Related]
55. [Summary of the practice guideline 'allergic and non-allergic rhinitis' (first revision) from the Dutch College of General Practitioners].
van Balen JA; Verduijn MM; Sachs AP; Berger MY; Lucassen PL; Wiersma TJ; Goudswaard AN
Ned Tijdschr Geneeskd; 2007 Oct; 151(41):2261-5. PubMed ID: 17987893
[TBL] [Abstract][Full Text] [Related]
56. The comparison of cetirizine, levocetirizine and placebo for the treatment of childhood perennial allergic rhinitis.
Lee CF; Sun HL; Lu KH; Ku MS; Lue KH
Pediatr Allergy Immunol; 2009 Aug; 20(5):493-9. PubMed ID: 19175892
[TBL] [Abstract][Full Text] [Related]
57. Clinical efficacy of ebastine in the treatment and prevention of seasonal allergic rhinitis.
Peláez A
Drugs; 1996; 52 Suppl 1():35-8. PubMed ID: 8828025
[TBL] [Abstract][Full Text] [Related]
58. Quality of life outcomes with sublingual immunotherapy.
Wise SK; Woody J; Koepp S; Schlosser RJ
Am J Otolaryngol; 2009; 30(5):305-11. PubMed ID: 19720247
[TBL] [Abstract][Full Text] [Related]
59. Healthcare professional versus patient goal setting in intermittent allergic rhinitis.
O'Connor J; Seeto C; Saini B; Bosnic-Anticevich S; Krass I; Armour C; Smith L
Patient Educ Couns; 2008 Jan; 70(1):111-7. PubMed ID: 17997261
[TBL] [Abstract][Full Text] [Related]
60. The ARIA guidelines in specialist practice: a nationwide survey.
Van Hoecke H; Van Cauwenberge P; Thas O; Watelet JB
Rhinology; 2010 Mar; 48(1):28-34. PubMed ID: 20502732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
